Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3585
Selected: 0
NCT IDTitle
NCT04504513Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer
NCT03122860A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis
NCT04456296A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
NCT07024589First-in-Human Trial of Oral AN2-502998
NCT06874335A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
NCT05717920A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)
NCT04129580reSET-O RCT (Randomized Controlled Trial)
NCT06068946VK2735 for Weight Management Phase 2
NCT02830542SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
NCT04907942Ecological Momentary Assessment and Text Message Intervention for Stress Management
NCT04975256Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
NCT07637162Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
NCT06181227A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
NCT05896527A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis
NCT01607905Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
NCT02667873A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors
NCT06062069A Study of CT-868 in Type 1 Diabetes Mellitus
NCT04830137A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
NCT03163173A Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of GC4419 in Healthy Adult Subjects
NCT05753605My Experiences: Leveraging Digital Technologies to Better Understand Mental Health
NCT07283094FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
NCT01338883Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus
NCT02137356Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer
NCT02661022SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
NCT06597656A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74
NCT02196077Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT04442022A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT00413075Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
NCT00007657Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
NCT02745912Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants
NCT07373639A Long-term Follow-up Study in Patients Who Received BEAM-101
NCT01037036A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG
NCT07303907A Phase 2A Trial of DT402 for Autism Spectrum Disorder
NCT05523765A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
NCT02651337Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters
NCT03617536A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
NCT02164006Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients
NCT02433834Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma
NCT00884234Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT03785964Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
NCT03193463Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy
NCT02618187A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
NCT04271514A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
NCT00646958Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
NCT04195399A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
NCT05980806A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
NCT05492734A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling
NCT05216432First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
NCT02279433A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
NCT03895944ET190L1-ARTEMIS™ T Cells in Relapsed, Refractory B Cell Leukemia and Lymphoma